Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,767,226
-
Share change
-
+3,045,018
-
Total reported value
-
$2,386,992,650
-
Put/Call ratio
-
262%
-
Price per share
-
$80.19
-
Number of holders
-
128
-
Value change
-
+$259,923,476
-
Number of buys
-
94
-
Number of sells
-
28
Institutional Holders of LOXO ONCOLOGY INC - COM (LOXO) as of Q2 2017
As of 30 Jun 2017,
LOXO ONCOLOGY INC - COM (LOXO) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,767,226 shares.
The largest 10 holders included
FMR LLC, Aisling Capital LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, VICTORY CAPITAL MANAGEMENT INC, and LORD, ABBETT & CO. LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.